Candida albicans (Pathogenesis): Difference between revisions

From MicrobeWiki, the student-edited microbiology resource
No edit summary
No edit summary
Line 20: Line 20:
===Description===
===Description===


<i>Candida albicans</i> is an opportunistic fungal pathogen that is responsible for candidiasis in human hosts. <i>C. albicans</i> grow in several different morphological forms, ranging from unicellular budding yeast to true hyphae with parallel-side wall (4). Typically, <i>C. albicans</i>live as harmless commensals in the gastrointestinal and genitourinary tract and are found in over 70% of the population. Overgrowth of these organisms, however, will lead to disease, and it usually occurs in immunocompromised individuals, such as HIV-infected victims, transplant recipients, chemotherapy patients, and low birth-weight babies (3). There are three major forms of disease: oropharyngeal candidiasis, vulvovaginal candidiasis, and invasive candidiasis. Over 75% of women will suffer from a <i>C. albicans</i> infection, usually vulvovaginal candidiasis, in their lifetimes, and 40-50% of them will have additional occurrences(s). Interestingly, <i>C. albicans</i> are the 4th leading cause for nosocomial infections in patients’ bloodstreams. This could result in an extremely life-threatening, systemic infection in hospital patients with a mortality rate of 30% (2).  For oropharyngeal candidiasis, infection occurs in the mouth or throat, and is identified by white plaque growth on oral mucous membranes. Vulvovaginal candidiasis or a “yeast infection” is the overgrowth of <i>C. albicans</i> in the vagina, and results in rash, itchiness, and discharge from the genital region. Lastly, invasive candidiasis occurs when the fungal pathogen enters the bloodstream and can easily spread to organs throughout the body. Invasive candidiasis is best identified when antibiotics fail to cure a patient’s fever (5). <i>C. albicans</i> infections are usually treatable with fluconazole, while severe infections require amphotericin B.  
<i>Candida albicans</i> is an opportunistic fungal pathogen that is responsible for candidiasis in human hosts. <i>C. albicans</i> grow in several different morphological forms, ranging from unicellular budding yeast to true hyphae with parallel-side wall [[#References|[1]]]. Typically, <i>C. albicans</i>live as harmless commensals in the gastrointestinal and genitourinary tract and are found in over 70% of the population. Overgrowth of these organisms, however, will lead to disease, and it usually occurs in immunocompromised individuals, such as HIV-infected victims, transplant recipients, chemotherapy patients, and low birth-weight babies [[#References|[2]]]. There are three major forms of disease: oropharyngeal candidiasis, vulvovaginal candidiasis, and invasive candidiasis. Over 75% of women will suffer from a <i>C. albicans</i> infection, usually vulvovaginal candidiasis, in their lifetimes, and 40-50% of them will have additional occurrences(s). Interestingly, <i>C. albicans</i> are the 4th leading cause for nosocomial infections in patients’ bloodstreams. This could result in an extremely life-threatening, systemic infection in hospital patients with a mortality rate of 30% [[#References|[3]]].  For oropharyngeal candidiasis, infection occurs in the mouth or throat, and is identified by white plaque growth on oral mucous membranes. Vulvovaginal candidiasis or a “yeast infection” is the overgrowth of <i>C. albicans</i> in the vagina, and results in rash, itchiness, and discharge from the genital region. Lastly, invasive candidiasis occurs when the fungal pathogen enters the bloodstream and can easily spread to organs throughout the body. Invasive candidiasis is best identified when antibiotics fail to cure a patient’s fever [[#References|[4]]]. <i>C. albicans</i> infections are usually treatable with fluconazole, while severe infections require amphotericin B.  


==Pathogenesis==
==Pathogenesis==
Line 83: Line 83:


==References==
==References==
1. Sudbery P, Gow N, Berman J. 2004. The distinct morphogenic states of <i>Candida albicans</i>. Trends in Microbiology. 12(7):317-24. <br>
2. Kabir MA, Hussain MA, Ahmad Z. 2012. <i>Candida albicans</i>: A Model Organism for Studying Fungal Pathogens. ISRN Microbiology. 2012: 538694. <br>
3. Pfaller MA, Diekema DJ. 2007. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Virulence. (2): 119–128. <br>
4. Centers for Disease Control and Prevention. Plague: Prevention. [<http://www.cdc.gov/fungal/diseases/candidiasis/index.html/>].<br>





Revision as of 16:16, 26 July 2014

This is a curated page. Report corrections to Microbewiki.
University of Oklahoma Study Abroad Microbiology in Arezzo, Italy[1]
Scanning electron microscope image of Candida albicans yeast cell. From: Science Photo Library [2]

Etiology/Bacteriology

Taxonomy

| Domain = Eukaryota | Phylum = Ascomycota | Class = Saccharomycetes | Order = Saccharomycetales | Family = Saccharomycetaceae | Genus = Candida | species = albicans

NCBI: Taxonomy Genome: Candida albicans

Description

Candida albicans is an opportunistic fungal pathogen that is responsible for candidiasis in human hosts. C. albicans grow in several different morphological forms, ranging from unicellular budding yeast to true hyphae with parallel-side wall [1]. Typically, C. albicanslive as harmless commensals in the gastrointestinal and genitourinary tract and are found in over 70% of the population. Overgrowth of these organisms, however, will lead to disease, and it usually occurs in immunocompromised individuals, such as HIV-infected victims, transplant recipients, chemotherapy patients, and low birth-weight babies [2]. There are three major forms of disease: oropharyngeal candidiasis, vulvovaginal candidiasis, and invasive candidiasis. Over 75% of women will suffer from a C. albicans infection, usually vulvovaginal candidiasis, in their lifetimes, and 40-50% of them will have additional occurrences(s). Interestingly, C. albicans are the 4th leading cause for nosocomial infections in patients’ bloodstreams. This could result in an extremely life-threatening, systemic infection in hospital patients with a mortality rate of 30% [3]. For oropharyngeal candidiasis, infection occurs in the mouth or throat, and is identified by white plaque growth on oral mucous membranes. Vulvovaginal candidiasis or a “yeast infection” is the overgrowth of C. albicans in the vagina, and results in rash, itchiness, and discharge from the genital region. Lastly, invasive candidiasis occurs when the fungal pathogen enters the bloodstream and can easily spread to organs throughout the body. Invasive candidiasis is best identified when antibiotics fail to cure a patient’s fever [4]. C. albicans infections are usually treatable with fluconazole, while severe infections require amphotericin B.

Pathogenesis

Transmission

Fleas

Fluid/Tissue

Infectious Droplets

Infectious dose, incubation, colonization

Epidemiology

United States

Worldwide

Virulence factors

Adhesion/invasion

Nutrient acquisition

Type III secretion system

Yop effectors

Anti-phagocytic antigens

Clinical features

Symptoms

Bubonic Plague

Septicemic Plague

Pneumonic Plague

Morbidity and Mortality

Diagnosis

Treatment

Antibiotics

Prophylaxis

Prevention

Host Immune Response

Attack on Innate Immune Response

Attack on Adaptive Immune Response

Host Immune Response

References

1. Sudbery P, Gow N, Berman J. 2004. The distinct morphogenic states of Candida albicans. Trends in Microbiology. 12(7):317-24.

2. Kabir MA, Hussain MA, Ahmad Z. 2012. Candida albicans: A Model Organism for Studying Fungal Pathogens. ISRN Microbiology. 2012: 538694.

3. Pfaller MA, Diekema DJ. 2007. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Virulence. (2): 119–128.

4. Centers for Disease Control and Prevention. Plague: Prevention. [<http://www.cdc.gov/fungal/diseases/candidiasis/index.html/>].



Created by Johnson Ong, a student of Tyrrell Conway at the University of Oklahoma.